 SOUTH SAN FRANCISCO, Calif., June 16, 2021 GLOBE NEWSWIRE -- VistaGen Therapeutics, Inc . NASDAQ: VTGN, a biopharmaceutical company committed to developing and commercializing a new generation of medicines with the potential to go beyond the current standard of care for anxiety, depression and other central nervous system CNS disorders, today announced the Company will be added to the Russell 2000 Index at the conclusion of the 2021 Russell Indexes annual reconstitution, effective after the U.S. market opens on Monday, June 28, 2021, according to a preliminary list of additions posted on June 4, 2021. 